natgillin/translations-raw huggingface dataset:
CONDITIONS OR RESTRICTIONS REGARDING SUPPLY OR USE Veterinary medicinal product subject to prescription.
B POGOJI TER OMEJITVE GLEDE OSKRBE IN UPORABE Na veterinarski recept.
Do not mix with any other veterinary medicinal product.
6.2 Glavne inkompatibilnosti Ne mešajte z nobenim drugim zdravilom za uporabo v veterinarski medicini.
Fevaxyn Pentofel stimulates the development of active immunity against feline panleucopenia virus, feline rhinotracheitis virus, feline calicivirus, Chlamydophila felis and feline leukaemia virus.
Cepivo stimulira nastanek aktivne imunosti proti virusom mačje panleukopenije, mačjega rinotraheitisa, mačjim calicivirusom, Chlamydophila felis.
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION 1 ml.
ODMERKI ZA POSAMEZNE ŽIVALSKE VRSTE TER POT(I) IN NAČIN UPORABE ZDRAVILA
A local reaction with swelling, pain, pruritis or hair loss at the injection site may be observed.
Včasih se na mestu cepljenja pojavi oteklina, bolečina, srbenje ali izguba dlake.
Vaccination does not affect the course of feline leukaemia virus (FeLV) infection in cats already infected with FeLV at the time of vaccination, implying that such cats will excrete FeLV irrespective of vaccination; consequently, these animals will constitute a hazard to susceptible cats in their environment.
Cepljenje nima učinka na potek infekcije z virusom mačje levkemije (FeLV) pri mačkah, ki so v času cepljenja že okužene s povzročitelji FeLV.
MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE
PROIZVAJALEC (PROIZVAJALCI) BIOLOŠKE (BIOLOŠKIH) UČINKOVINE (UČINKOVIN) IN PROIZVAJALEC (PROIZVAJALCI) ZDRAVILA, ODGOVOREN (ODGOVORNI) ZA SPROŠČANJE SERIJ
PARTICULARS TO APPEAR ON THE OUTER PACKAGE BOX OF 10 x 1 ML SINGLE DOSE SYRINGES, 20 x 1 ML SINGLE DOSE SYRINGES , 25 x 1 ML SINGLE DOSE SYRINGES
ŠKATLA 10 X 1 ML ENOODMERNA BRIZGA, 20 X 1 ML ENOODMERNA BRIZGA, 25 X 1 ML ENOODMERNA BRIZGA
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS SINGLE DOSE SYRINGE
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Adjuvants
Učinkovine
25 x 1 ml presentation: Box containing 25 single dose prefilled syringes and 25 sterile needles.
25 x 1 ml pakiranje: kartonska škatla z 25 napolnjenimi enoodmernimi brizgami in z 25 sterilnimi iglami.
The contents of the single dose syringe should be shaken well and administered aseptically by subcutaneous injection.
NASVET O PRAVILNI UPORABI ZDRAVILA Vsebino enoodmerne brizge pred uporabo pretresemo in apliciramo subkutano.
Inactivated feline panleucopenia virus, strain CU4 Inactivated feline calicivirus, strain 255
Inaktiviran mačji calicivirus, sev 255
20 x 1 ml presentation: Box containing 20 single dose prefilled syringes and 20 sterile needles.
20 x 1 ml pakiranje: kartonska škatla z 20 napolnjenimi enoodmernimi brizgami in z 20 sterilnimi iglami.
NAME OF THE VETERINARY MEDICINAL PRODUCT Fevaxyn Pentofel suspension for injection for cats
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Fevaxyn Pentofel suspenzija za injiciranje za mačke
10 x 1 ml presentation: Box containing 10 single dose prefilled syringes and 10 sterile needles.
10 x 1 ml pakiranje: kartonska škatla z 10 napolnjenimi enoodmernimi brizgami in z 10 sterilnimi iglami.
PACKAGE LEAFLET: Fevaxyn Pentofel, suspension for injection for cats
NAVODILO ZA UPORABO Fevaxyn Pentofel, suspenzija za injiciranje za mačke
The safety of the vaccine in pregnant queens has not been investigated.
Nosečnost: Varnost cepiva pri brejih mačkah ni bila raziskana, zato se ne priporoča cepljenja brejih mačk.
Vaccination does not affect the course of FeLV infection in cats already infected with FeLV at the time of vaccination, implying that such cats will excrete FeLV irrespective of vaccination; consequently, these animals will constitute a hazard to susceptible cats in their environment.
Te mačke izločajo FeLV ne glede na cepljenje in predstavljajo veliko nevarnost kot vektor okužb v okolju za druge mačke.
Inactivated feline rhinotracheitis virus, strain 605 Inactivated Chlamydophila felis, strain Cello Inactivated feline leukaemia virus, strain 61E
Inaktiviran virus mačjega rinotraheitisa, sev 605
NAME OF THE VETERINARY MEDICINAL PRODUCT Fevaxyn Pentofel for cats
Fevaxyn Pentofel za mačke
Subcutaneous use.
Odmerek znaša 1 ml. Subkutana uporaba.
50 mg Film-coated tabletOral use blister (alu/alu)
50 mg filmsko obložene tablete peroralna uporaba pretisni omot (aluminij/aluminij)
Strength Pharmaceutical Form
Jakost Farmacevtska oblika Pot uporabe Stična ovojnina Velikost pakiranja
2 These are medicinal products within class where similar interactions could be predicted.
2 To so zdravila znotraj razreda, kjer je mogoče predvideti podobne interakcije.
This may become severe or potentially life-threatening.
To lahko postane resno ali potencialno življenjsko nevarno.
A nutritional drink alone does not replace food.
Samo hranljivi napitek ne nadomesti hrane.
Where possible, alternatives such as azithromycin should be considered.
Kjer je možno, je treba razmisliti o alternativnih zdravilih, kot je azitromicin.
• If you are currently taking any of the following medicines
• Če trenutno uporabljate katero koli od naslednjih zdravil
a Week 24 window is between day 127 and 210 (inclusive).
a Okno v 24. tednu je med 127. in 210. dnevom (vključno z njima).
ATC code: J05AR08.
Oznaka ATC: J05AR08.
The virus may then become harder to treat.
Nato bo morda virus še težje zdraviti.
If you are taking rifabutin.
Če jemljete rifabutin.
This is important to get the right levels of active substance in your body.
To je pomembno, da dobite pravilne ravni učinkovine v telo.
Cimetidine2 Nizatidine2 Ranitidine2
cimetidin2 nizatidin2 ranitidin2
Talk to your doctor about an alternative regimen.
Z zdravnikom se pogovorite o alternativnem režimu.
Resistance to tenofovir (K65R)
Rezistenca na tenofovir (K65R)
Demographic Characteristics Median age (range), years
Demografske značilnosti Mediana starost (razpon), leta
• Depression and depressed mood
• depresija in depresivno razpoloženje
See section 4.8, Description of selected adverse reactions.
Glejte poglavje 4.8, Opis izbranih neželenih učinkov.
Alternatively, switching to another antiretroviral regimen could be considered.
Druga možnost je, da se razmisli o prehodu na drug protiretrovirusni režim.
Pregnant women should not take Eviplera unless you and your doctor decide it is clearly needed.
Noseče ženske ne smejo jemati zdravila Eviplera, razen če ste se vi in vaš zdravnik odločili, da je to nujno potrebno.
This should be considered when assessing a patient's ability to drive or operate machinery.
To je treba upoštevati pri ocenjevanju bolnikove sposobnosti vožnje ali upravljanja strojev.
Non-response Virologic failure (all patients)
Neodzivni Virološki neuspeh (vsi bolniki)
Virologic failure and development of resistance
Virološki neuspeh in razvoj rezistence
In patients with phenotypic data (n = 66)
Pri bolnikih s fenotipskimi podatki (n = 66)
• Antibiotics used to treat bacterial infections including tuberculosis containing:
• Antibiotiki, ki se uporabljajo za zdravljenje bakterijskih okužb, vključno s tuberkulozo, ki vsebujejo:
This, will improve your immune system and reduces the risk of developing illnesses linked to HIV infection.
S tem se vaš imunski sistem izboljša in zmanjša se tveganje za razvoj bolezni, povezanih z okužbo s HIV.
• This is because the active substances in this medicine pass into human breast milk.
• To je zato, ker učinkovine tega zdravila prehajajo v materino mleko.
Effects on electrocardiogram
Učinki na elektrokardiogram
Tenofovir concentrations not measured, no effect is expected.
Koncentracij tenofovira niso merili, učinkov se ne pričakuje.
 Tell your doctor immediately about new or unusual symptoms after you stop treatment, particularly symptoms you associate with hepatitis B infection.
 Nemudoma obvestite zdravnika o vsakem novem ali nenavadnem simptomu potem, ko ste prenehali z zdravljenjem, še posebej o simptomih, ki jih povezujete z okužbo s hepatitisom B.
Further management should be as clinically indicated or as recommended by the national poisons centre, where available.
Nadaljnje zdravljenje mora potekati, kot je klinično indicirano ali v skladu s priporočili nacionalnega centra za zastrupitve, če je na voljo.
Your doctor may need to give you an additional dose of rilpivirine.
Vaš zdravnik vam bo morda moral dati dodatni odmerek rilpivirina.
Interaction studies with these active substances have only been performed in adults.
Študije medsebojnega delovanja s temi učinkovinami so izvedli le pri odraslih.
Treatment outcomes through 24 weeks are presented in Table 7.
Izidi zdravljenja do konca 24. tedna so predstavljeni v preglednici 7.
Virologic success after 24 weeks of treatmentb
Virološki uspeh po 24. tednih zdravljenjab
• Any other medicines containing:
• Katero koli drugo zdravilo, ki vsebuje:
Your doctor may need to change the dose of the antibiotic or give you a different antibiotic.
Vaš zdravnik bo morda moral spremeniti odmerek antibiotika ali vam dati drugi antibiotik.
• Tell your doctor immediately if you become pregnant or if you plan to become pregnant.
• Zdravnika takoj obvestite, če zanosite ali če načrtujete zanositev.
Your doctor will discuss the potential benefits and risks of taking Eviplera to you and your child.
Vaš zdravnik se bo z vami pogovoril o možnih koristih in tveganjih zdravljenja z zdravilom Eviplera za vas in vašega otroka.
In general, the pharmacokinetics of emtricitabine in infants, children and adolescents (aged 4 months up to 18 years) is similar to those seen in adults.
Na splošno so farmakokinetične lastnosti emtricitabina pri dojenčkih, otrocih in mladostnikih (v starosti od 4 mesecev do 18 let) podobne tistim, ki so bile opažene pri odraslih.
Wait and take the next dose, with food, at your usual time.
Počakajte in vzemite naslednji odmerek s hrano ob vašem običajnem času.
Eviplera reduces the amount of HIV in your body.
Zdravilo Eviplera zmanjša količino virusa HIV v vašem telesu.
If you are over 65 years of age and are prescribed Eviplera, your doctor will monitor you carefully.
Če ste stari več kot 65 let in so vam predpisali zdravilo Eviplera, vas bo zdravnik skrbno nadziral.
If you have hepatitis B, your doctor will carefully consider the best treatment regimen for you.
Če imate hepatitis C, bo zdravnik natančno preučil najboljši režim zdravljenja za vas.
In vitro binding of rilpivirine to human plasma proteins is approximately 99.7%, primarily to albumin.
In vitro vezava rilpivirina na humane plazemske proteine je približno 99,7 %, primarno na albumin.
Date of first authorisation: 28 November 2011 Date of latest renewal: 22 July 2016
Datum zadnjega podaljšanja: 22. julij 2016
The absolute bioavailability of emtricitabine from 200 mg hard capsules was estimated to be 93%.
Absolutna biološka uporabnost emtricitabina iz 200 mg trde kapsule je bila ocenjena s 93 %.
Interrupting treatment with Eviplera should also be considered in case of progressive decline of renal function when no other cause has been identified.
O prekinitvi zdravljenja z zdravilom Eviplera je treba razmisliti tudi v primeru progresivnega upada ledvične funkcije, če ni bil ugotovljen noben drug razlog.
increased bilirubin1, 2
zvišanje bilirubina1, 2
There were no new cross-resistance patterns at week 96 compared to week 48.
Novih vzorcev navzkrižne rezistence v 96. tednu v primerjavi z 48. tednom ni bilo.
• If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
• Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se pred uporabo tega zdravila posvetujte s svojim zdravnikom.
For the resistance analyses, a broader definition of virologic failure was used than in the primary efficacy analysis.
Za analizo rezistence so uporabili širšo opredelitev virološkega neuspeha kot za analizo primarne učinkovitosti.
• Medicines that may damage your kidneys, examples include:
• Zdravila, ki lahko poškodujejo ledvice, primeri vključujejo:
Decreases in BMD of hip were significantly greater in this group until 96 weeks.
Zmanjšanje BMD v kolku je bilo do 96 tednov pomembno večje v tej skupini.
• Swelling of the face, lips, tongue or throat
• oteklost obraza, ustnic, jezika ali grla
3 Phenotypic resistance (Antivirogram).
2 Fenotipska rezistenca (Antivirogram).
Stopping Eviplera can seriously affect your response to future treatment.
Prenehanje jemanja zdravila Eviplera lahko resno vpliva na vaš odziv na prihodnje zdravljenje.
Patients had a mean age of 42 years (range 19-73), 88% were male, 77% were White, 17% were Black, and 17% were Hispanic/Latino.
Bolniki so bili povprečno stari 42 let (razpon 19-73), 88 % je bilo moških, 77 % je bilo belcev, 17 % je bilo črncev in 17 % jih je bilo španskega/latinskoameriškega porekla.
Your doctor will carefully consider whether to treat you with other medicines used for treating HIV infection (see Other medicines used for HIV infection).
Vaš zdravnik bo skrbno pretehtal, če vas bo zdravil z drugimi zdravili za zdravljenje okužb s HIV (glejte Druga zdravila, ki se uporabljajo za okužbe z virusom HIV).
No virologic data in week 24 window
V oknu 24. tedna ni viroloških podatkov
• Deep, rapid breathing
• globoko, hitro dihanje
Concomitant use where caution is recommended
Sočasna uporaba, pri kateri je potrebna pazljivost
There are no adequate and well-controlled studies of Eviplera or its components in pregnant women.
Ni zadostnih in dobro nadzorovanih študij zdravila Eviplera ali njegovih sestavin pri nosečnicah.
Eviplera has no or negligible influence on the ability to drive and use machines.
Zdravilo Eviplera nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
The combination of Eviplera and dabigatran etexilate should be used with caution.
Kombinacijo zdravila Eviplera in dabigatran eteksilata je treba uporabljati previdno.
What Eviplera is and what it is used for
Kaj je zdravilo Eviplera in za kaj ga uporabljamo
• interleukin-2, also called aldesleukin (to treat cancer)
• interlevkin-2, imenuje se tudi aldeslevkin (za zdravljenje raka)
This includes medicines and herbal medicines obtained without a prescription.
To velja tudi za zdravila in zeliščne pripravke, ki ste jih dobili brez recepta.
 Tell your doctor if you are taking any of these medicines.
 Obvestite zdravnika, če jemljete katerega od teh zdravil.
The efficacy data from study GS-US-264-0111 (see section 5.1) indicates that the brief period of lower rilpivirine exposure does not impact antiviral efficacy of Eviplera.
Podatki o učinkovitosti iz študije GS-US-264-0111 (glejte poglavje 5.1) kažejo, da kratka obdobja nižje izpostavljenosti rilpivirinu ne vplivajo na protivirusno učinkovitost zdravila Eviplera.
Resistance to emtricitabine/lamivudine (M184I/V)
Rezistenca na emtricitabin/lamivudin (M184I/V)
The terminal elimination half-life of rilpivirine is approximately 45 hours.
Končna razpolovna doba rilpivirina je približno 45 ur.
• If you have taken Eviplera during your pregnancy, your doctor may request regular blood tests and other diagnostic tests to monitor the development of your child.
• Če ste zdravilo Eviplera jemali med nosečnostjo, vas lahko zdravnik naroči na redne preiskave krvi in druge diagnostične preiskave, da bo spremljal razvoj vašega otroka.
Alternatively, switching to another antiretroviral regimen could be considered (see sections 4.4, 4.6, 5.1 and 5.2).
Druga možnost je, da se razmisli o prehodu na drug protiretrovirusni režim (glejte poglavja 4.4, 4.6, 5.1 in 5.2).
Due to the decline in efavirenz plasma levels, the inductive effect decreased and rilpivirine concentrations started to normalise.
Zaradi zmanjšanja ravni efavirenza v plazmi se je induktivni učinek zmanjšal in koncentracije rilpivirina so se začele normalizirati.
• Rifabutin, a medicine to treat some bacterial infections.
• Rifabutin, zdravilo, ki se uporablja za zdravljenje nekaterih bakterijskih okužb.
• Increased levels of creatine kinase in the blood that may result in muscle pain and weakness
• povišane ravni kreatin kinaze v krvi, ki lahko povzročijo bolečine in oslabelost mišic
Talk to your doctor about an alternative regimen (see section 3, How to take Eviplera).
Z zdravnikom se pogovorite o alternativnem režimu (glejte poglavje 3, Kako jemati zdravilo Eviplera).
Insufficient safety data are available for children under the age of 18 years.
Za otroke stare do 18 let so podatki o varnosti nezadostni.
• Difficulty sleeping (insomnia)
• težave s spanjem (nespečnost)
Your doctor will discuss a different medicine if required.
Vaš zdravnik se bo po potrebi z vami dogovoril za drugo zdravilo.
The E138K substitution emerged most frequently during rilpivirine treatment, commonly in combination with the M184I substitution.
Substitucija E138K se je najpogosteje pojavila pri zdravljenju z rilpivirinom, pogosto v kombinaciji s substitucijo M184I.
In the studies, the presence of the mutations V90I and V189I at baseline did not affect the response.
V študijah prisotnost mutacij V90I in V189I na začetku ni vplivala na odziv.
This is partly linked to restored health and life style, and in the case of blood lipids sometimes to the HIV medicines themselves.
To je lahko deloma povezano z obnovljenim zdravjem in življenjskim slogom, pri krvnih lipidih pa občasno tudi s samimi zdravili za zdravljenje okužbe z virusom HIV.
Maximum tenofovir concentrations are observed in plasma within 2 hours and maximum plasma concentrations of rilpivirine are generally achieved within 4-5 hours.
Največje koncentracije tenofovira so opazili v plazmi v roku 2 ur in največje koncentracije rilpivirina v plazmi so običajno dosežene v roku 4-5 ur.
Do not chew, crush or split the tablet - if you do it may affect the way the medicine is released into your body.
Tablete ne žvečite, drobite ali delite - to lahko vpliva na način sproščanja zdravila v vašem telesu.
It is not considered to be causally associated with tenofovir disoproxil in the absence of this condition.
Ne smatra se kot vzročno povezan z dizoproksiltenofoviromat v odsotnosti tega stanja.
• Damage to kidney tubule cells
• poškodbe celic ledvičnih tubulov
In dogs cholestasis-like effects were noted.
Pri psih so opazili učinke, podobne holestazi.
The safety and efficacy of Eviplera in children under the age of 18 years have not been established.
Varnost in učinkovitost zdravila Eviplera pri otrocih, starih pod 18 let, nista bili dokazani.
However, clinical monitoring is recommended as methadone maintenance therapy may need to be adjusted in some patients.
Vendar pa se priporoča klinično spremljanje, saj je morda pri nekaterih bolnikih treba prilagoditi vzdrževalno zdravljenje z metadonom.
The EC50 values for tenofovir were in the range of 0.04 to 8.5 µM.
Vrednosti EC50 za tenofovir so bile v razponu 0,04 do 8,5 µM.
Other effects that may be seen during HIV treatment
Drugi možni neželeni učinki, ki se lahko pojavijo med zdravljenjem okužbe z virusom HIV
e e.g. lost to follow up, non-compliance, withdrew consent.
e Npr. izgubljeni za spremljanje, neskladnost, umik soglasja.
The 50% effective concentration (EC50) values for emtricitabine were in the range of 0.0013 to 0.64 µM.
Vrednosti s 50-odstotno učinkovito koncentracijo (EC50) za emtricitabin so bile v razponu od 0,0013 do 0,64 µM.
There is not sufficient data to justify the use in patients with prior NNRTI failure.
Podatki ne zadoščajo za utemeljitev uporabe pri bolnikih s predhodno odpovedjo NNRTI.
Possible side effects: tell a doctor immediately
Možni neželeni učinki: takoj obvestite zdravnika
Do not drive or operate machines if you feel tired, sleepy or dizzy after taking your medicine.
Ne vozite avtomobila in ne upravljajte strojev, če ste po uporabi zdravila utrujeni, zaspani ali omotični.
Tell your doctor if you are taking any of the following:
Obvestite zdravnika, če uporabljate kaj od naslednjega:
• Lactic acidosis (excess lactic acid in the blood) is a rare but potentially life-threatening side effect of some HIV medicines.
• Laktacidoza (preveč mlečne kisline v krvi) je redek, a življenjsko nevaren neželeni učinek pri nekaterih zdravilih za zdravljenje HIV.
However, it may not be excluded that the pharmacologically active, unbound, rilpivirine exposure is significantly increased in moderate impairment.
Vendar pa ni mogoče izključiti, da se izpostavitev farmakološko aktivnemu, nevezanemu rilpivirinu pomembno poveča pri zmerni okvari.
If you are taking one of these medicines your doctor will either give you a different medicine for stomach ulcers, heartburn or acid reflux, or recommend how and when you take that medicine.
Če jemljete ta zdravila, vam bo zdravnik dal drugo zdravilo za razjede želodca, zgago ali refluks kisline ali priporočal, kako in kdaj naj zdravilo vzamete.
Not enough patients over the age of 65
Niso preučili dovolj bolnikov, starejših od 65 let.
Both emtricitabine and tenofovir have activity that is specific to HIV-1, HIV-2 and, HBV.
Tako emtricitabin kot tenofovir imata aktivnost, ki je specifična za HIV-1, HIV-2 in HBV.
De novo resistance to emtricitabine/lamivudine was seen in 4 cases, and also to rilpivirine in 2 cases, with a consequent cross-resistance to efavirenz (2/2), nevirapine (2/2) and etravirine (1/2).
Na novo nastalo rezistenco na emtricitabin/lamivudin so opazili v 4 primerih in tudi na rilpivirin v 2 primerih, s posledično navzkrižno rezistenco na efavirenz (2/2), nevirapin (2/2) in etravirin (1/2).
• Talk to your doctor if you have a history of liver disease, including hepatitis.
• Obvestite zdravnika, če imate jetrne bolezni v anamnezi, vključno s hepatitisom.
The most common mutations were the same in the week 48 and week 96 analyses.
Najpogostejše mutacije so bile v analizah 48. tedna in 96. tedna enake.
Population pharmacokinetic analysis in HIV infected patients showed that rilpivirine pharmacokinetics is not different across the age range (18 to 78 years) evaluated, with only 2 patients aged 65 years of age or older.
Populacijska farmakokinetična analiza bolnikov, okuženih z virusom HIV, je pokazala, da se farmakokinetika rilpivirina ne razlikuje glede na razpon ocenjene starosti (18 do 78 let), s samo 2 bolnikoma, starima 65 let ali več.
It is important not to stop taking Eviplera without talking to your doctor: see section 3, Do not stop taking Eviplera.
Pomembno je, da zdravila Eviplera ne prenehate jemati, ne da se pogovorite z zdravnikom: glejte poglavje 3, Ne prenehajte jemati zdravila Eviplera.
The studies are identical in design with the exception of the background regimen (BR).
Te študije so po zasnovi identične in se razlikujejo le po osnovni shemi zdravljenja (background regimen, BR).
Your doctor may do blood tests to see if your kidneys are working properly
Vaš zdravnik lahko opravi krvne preiskave, da ugotovi, ali vaše ledvice dobro delujejo
QT prolonging medicinal products
Zdravila, ki podaljšujejo QT
hepatitis3, hepatic steatosis3
hepatitis3, hepatična steatoza3
If you have HIV infection and hepatitis B, it is especially important not to stop your Eviplera treatment without talking to your doctor first.
Če ste okuženi z virusom HIV in hepatitisom B, je še zlasti pomembno, da ne prenehate z zdravljenjem z zdravilom Eviplera, ne da bi se prej posvetovali z zdravnikom.
• Increased levels of cholesterol and/or pancreatic amylase in the blood
• povišane ravni holesterola in/ali pankreasne amilaze v krvi
• Dabigatran etexilate, a medicine used to treat heart conditions, as your doctor may need to monitor the levels of this medicine in your blood.
• Dabigatran eteksilat, zdravilo, ki se uporablja za zdravljenje bolezni srca, saj bo moral zdravnik morda nadzirati ravni tega zdravila v vaši krvi.
The oral bioavailability of tenofovir from tenofovir disoproxil tablets in fasted patients was approximately 25%.
Peroralna biološka uporabnost tenofovirja iz tablet dizoproksiltenofovirata pri bolnikih na tešče je bila približno 25 %.